Rapid diagnostic tests for global impact. Our vision is to be disruptive in bringing a new platform for rapid diagnostics using aptamers to healthcare, veterinary medicines, food and agriculture businesses. Operational since 2017, we are the first Australian biotech to deliver highly customised aptamer discovery and development services – from research, development, manufacturing and distribution – we manage and deliver completely validated rapid diagnostic tests.
| Website | http://www.dxventures.com.au |
| Employees | 3 (1 on RocketReach) |
| Address | 4/27 Rose Cres, Regents Park, New South Wales 2143, AU |
| Technologies | |
| Industry | Medical Equipment Manufacturing |
| Keywords | Rapid Diagnostic Tests, Rapid Testing, Healthcare Diagnostics, Diagnostic Assays, Molecular Diagnostics, Diagnostic Platform, In Vitro Diagnostics, Diagnostic Technologies, Clinical Diagnostics, Diagnostic Solutions, Point Of Care Diagnostics, Biosensors, Veterinary Diagnostics, Life Sciences, Biotechnology, Agricultural Diagnostics, Medical Devices, Global Health |
Looking for a particular DxVentures employee's phone or email?
DxVentures Questions
Nghi Phung is the CEO and Co-Founder of DxVentures.
1 people are employed at DxVentures.
DxVentures is based in Regents Park, New South Wales.
Top DxVentures Employees
-
Nghi Phung
CEO and Co-Founder at DxVentures
Sydney, NSW, AU
